Clinical Trial Update: To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety and pharmacokinetics interactions between olaparib and endocrine therapies (anastrozole, letrozole, tamoxifen) in advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Cancer
• Solid Tumors

Drugs mentioned

• Anastrozole (Anastrozole)
• Letrozole (letrozole)
• Olaparib (Olaparib)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Solid Tumours | Phase 1 | Status: COMPLETED | Results posted: 2016-06-01